# Westlake Chemical Partners LP: financial statements, quarterly

WLKP · NYSE · CIK 1604665 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wlkp.md) · [Financials](/companies/wlkp/financials.md) · [Filings](/companies/wlkp/filings.md) · [Insiders](/companies/wlkp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wlkp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [322](/filings/0001604665-24-000037.md) | [297 d](/filings/0001604665-26-000010.md) | [285](/filings/0001604665-25-000021.md) | [284](/filings/0001604665-25-000034.md) | [277](/filings/0001604665-25-000042.md) | [290 d](/filings/0001604665-26-000010.md) | [238](/filings/0001604665-26-000017.md) | [297](/filings/0001604665-26-000027.md) | [309](/filings/0001604665-25-000042.md) | [323 d](/filings/0001604665-26-000010.md) | [306](/filings/0001604665-26-000017.md) | [297](/filings/0001604665-26-000027.md) |
| Cost of revenue | $m | [229](/filings/0001604665-24-000037.md) | [197 d](/filings/0001604665-26-000010.md) | [182](/filings/0001604665-25-000021.md) | [183](/filings/0001604665-25-000034.md) | [160](/filings/0001604665-25-000042.md) | [191 d](/filings/0001604665-26-000010.md) | [184](/filings/0001604665-26-000017.md) | [200](/filings/0001604665-26-000027.md) | [209](/filings/0001604665-25-000042.md) | [226 d](/filings/0001604665-26-000010.md) | [212](/filings/0001604665-26-000017.md) | [202](/filings/0001604665-26-000027.md) |
| Gross profit | $m | [93.0](/filings/0001604665-24-000037.md) | [101 d](/filings/0001604665-26-000010.md) | [102](/filings/0001604665-25-000021.md) | [101](/filings/0001604665-25-000034.md) | [117](/filings/0001604665-25-000042.md) | [98.6 d](/filings/0001604665-26-000010.md) | [54.1](/filings/0001604665-26-000017.md) | [97.5](/filings/0001604665-26-000027.md) | [99.4](/filings/0001604665-25-000042.md) | [96.8 d](/filings/0001604665-26-000010.md) | [93.8](/filings/0001604665-26-000017.md) | [94.8](/filings/0001604665-26-000027.md) |
| Selling, general and administrative | $m | [6.7](/filings/0001604665-24-000037.md) | [7.9 d](/filings/0001604665-26-000010.md) | [7.1](/filings/0001604665-25-000021.md) | [7.6](/filings/0001604665-25-000034.md) | [7.3](/filings/0001604665-25-000042.md) | [6.6 d](/filings/0001604665-26-000010.md) | [7.5](/filings/0001604665-26-000017.md) | [6.3](/filings/0001604665-26-000027.md) | [7.4](/filings/0001604665-25-000042.md) | [7.1 d](/filings/0001604665-26-000010.md) | [7.2](/filings/0001604665-26-000017.md) | [7.5](/filings/0001604665-26-000027.md) |
| Operating income | $m | [86.2](/filings/0001604665-24-000037.md) | [92.8 d](/filings/0001604665-26-000010.md) | [95.1](/filings/0001604665-25-000021.md) | [93.6](/filings/0001604665-25-000034.md) | [110](/filings/0001604665-25-000042.md) | [92.0 d](/filings/0001604665-26-000010.md) | [46.6](/filings/0001604665-26-000017.md) | [91.2](/filings/0001604665-26-000027.md) | [92.0](/filings/0001604665-25-000042.md) | [89.8 d](/filings/0001604665-26-000010.md) | [86.6](/filings/0001604665-26-000017.md) | [87.3](/filings/0001604665-26-000027.md) |
| Interest expense | $m | not reported | not reported | [6.6](/filings/0001604665-25-000021.md) | [6.7](/filings/0001604665-25-000034.md) | [6.7](/filings/0001604665-25-000042.md) | [5.8 d](/filings/0001604665-26-000010.md) | [5.5](/filings/0001604665-26-000017.md) | [5.9](/filings/0001604665-26-000027.md) | [5.9](/filings/0001604665-25-000042.md) | [5.5 d](/filings/0001604665-26-000010.md) | [5.1](/filings/0001604665-26-000017.md) | [5.1](/filings/0001604665-26-000027.md) |
| Income tax | $m | [0.2](/filings/0001604665-24-000037.md) | [0.2 d](/filings/0001604665-26-000010.md) | [0.2](/filings/0001604665-25-000021.md) | [0.2](/filings/0001604665-25-000034.md) | [0.2](/filings/0001604665-25-000042.md) | [0.2 d](/filings/0001604665-26-000010.md) | [0.1](/filings/0001604665-26-000017.md) | [0.2](/filings/0001604665-26-000027.md) | [0.0](/filings/0001604665-25-000042.md) | [0.2 d](/filings/0001604665-26-000010.md) | [0.2](/filings/0001604665-26-000017.md) | [0.2](/filings/0001604665-26-000027.md) |
| Net income | $m | [13.2](/filings/0001604665-24-000037.md) | [14.3 d](/filings/0001604665-26-000010.md) | [14.8](/filings/0001604665-25-000021.md) | [14.4](/filings/0001604665-25-000034.md) | [18.1](/filings/0001604665-25-000042.md) | [15.0 d](/filings/0001604665-26-000010.md) | [4.9](/filings/0001604665-26-000017.md) | [14.6](/filings/0001604665-26-000027.md) | [14.7](/filings/0001604665-25-000042.md) | [14.5 d](/filings/0001604665-26-000010.md) | [14.2](/filings/0001604665-26-000017.md) | [14.2](/filings/0001604665-26-000027.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [65.9](/filings/0001604665-23-000033.md) | [58.6](/filings/0001604665-25-000011.md) | [55.8](/filings/0001604665-24-000018.md) | [66.0](/filings/0001604665-24-000029.md) | [60.2](/filings/0001604665-24-000037.md) | [58.3](/filings/0001604665-26-000010.md) | [49.6](/filings/0001604665-25-000021.md) | [36.6](/filings/0001604665-25-000034.md) | [37.9](/filings/0001604665-25-000042.md) | [44.3](/filings/0001604665-26-000027.md) | [44.3](/filings/0001604665-26-000017.md) | [49.3](/filings/0001604665-26-000027.md) |
| Current assets | $m | [231](/filings/0001604665-23-000033.md) | [226](/filings/0001604665-25-000011.md) | [224](/filings/0001604665-24-000018.md) | [232](/filings/0001604665-24-000029.md) | [242](/filings/0001604665-24-000037.md) | [241](/filings/0001604665-26-000010.md) | [225](/filings/0001604665-25-000021.md) | [157](/filings/0001604665-25-000034.md) | [131](/filings/0001604665-25-000042.md) | [144](/filings/0001604665-26-000027.md) | [149](/filings/0001604665-26-000017.md) | [158](/filings/0001604665-26-000027.md) |
| Total assets | $m | [1,342](/filings/0001604665-23-000033.md) | [1,317](/filings/0001604665-25-000011.md) | [1,295](/filings/0001604665-24-000018.md) | [1,288](/filings/0001604665-24-000029.md) | [1,295](/filings/0001604665-24-000037.md) | [1,288](/filings/0001604665-26-000010.md) | [1,371](/filings/0001604665-25-000021.md) | [1,307](/filings/0001604665-25-000034.md) | [1,272](/filings/0001604665-25-000042.md) | [1,257](/filings/0001604665-26-000027.md) | [1,236](/filings/0001604665-26-000017.md) | [1,217](/filings/0001604665-26-000027.md) |
| Current liabilities | $m | [75.6](/filings/0001604665-23-000033.md) | [56.3](/filings/0001604665-25-000011.md) | [43.1](/filings/0001604665-24-000018.md) | [49.6](/filings/0001604665-24-000029.md) | [53.3](/filings/0001604665-24-000037.md) | [55.4](/filings/0001604665-26-000010.md) | [165](/filings/0001604665-25-000021.md) | [72.9](/filings/0001604665-25-000034.md) | [55.1](/filings/0001604665-25-000042.md) | [51.3](/filings/0001604665-26-000027.md) | [40.8](/filings/0001604665-26-000017.md) | [45.8](/filings/0001604665-26-000027.md) |
| Total liabilities | $m | [480](/filings/0001604665-23-000033.md) | [461](/filings/0001604665-25-000011.md) | [447](/filings/0001604665-24-000018.md) | [454](/filings/0001604665-24-000029.md) | [457](/filings/0001604665-24-000037.md) | [459](/filings/0001604665-26-000010.md) | [568](/filings/0001604665-25-000021.md) | [476](/filings/0001604665-25-000034.md) | [458](/filings/0001604665-25-000042.md) | [454](/filings/0001604665-26-000027.md) | [443](/filings/0001604665-26-000017.md) | [448](/filings/0001604665-26-000027.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [101 d](/filings/0001604665-24-000037.md) | [108 d](/filings/0001604665-26-000010.md) | [105](/filings/0001604665-25-000021.md) | [122 d](/filings/0001604665-25-000034.md) | [126 d](/filings/0001604665-25-000042.md) | [132 d](/filings/0001604665-26-000010.md) | [45.8](/filings/0001604665-26-000017.md) | [9.1 d](/filings/0001604665-26-000027.md) | [105 d](/filings/0001604665-25-000042.md) | [120 d](/filings/0001604665-26-000010.md) | [110](/filings/0001604665-26-000017.md) | [130 d](/filings/0001604665-26-000027.md) |
| Capital expenditure | $m | [16.8 d](/filings/0001604665-24-000037.md) | [12.8 d](/filings/0001604665-26-000010.md) | [9.8](/filings/0001604665-25-000021.md) | [10.2 d](/filings/0001604665-25-000034.md) | [15.5 d](/filings/0001604665-25-000042.md) | [13.5 d](/filings/0001604665-26-000010.md) | [16.0](/filings/0001604665-26-000017.md) | [24.4 d](/filings/0001604665-26-000027.md) | [29.7 d](/filings/0001604665-25-000042.md) | [8.8 d](/filings/0001604665-26-000010.md) | [5.6](/filings/0001604665-26-000017.md) | [12.5 d](/filings/0001604665-26-000027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Shares outstanding: 35,245,879 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0001604665-26-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.